Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction

Clinical trial NCT04049539 · RECRUITING

Trial details

NCT number: NCT04049539
Sponsor: Ohio State University Comprehensive Cancer Center
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Blasts More Than 5 Percent of Bone Marrow Nucleated Cells Persistent Disease Refractory Acute Myeloid Leukemia

Start date: 2021-01-29
Primary completion: 2026-12-31
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.